ThesisInterleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection
ThesisInterleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection
ThesisRelation between Osteopontin gene polymorphism & its protein level and the efficacy of interferon-based therapies in HCV patients
ThesisRelation between Osteopontin gene polymorphism & its protein level and the efficacy of interferon-based therapies in HCV patients
ThesisSingle nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children
ThesisSingle nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children
ThesisOsteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C
ThesisOsteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C
ThesisThe clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin
ThesisThe clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin
ThesisA study of interleukin-10 (IL-10) promoter gene polymorphisms and response to therapy in chronic hepatitis C infection in children
ThesisA study of interleukin-10 (IL-10) promoter gene polymorphisms and response to therapy in chronic hepatitis C infection in children
ThesisInfluence of vitamin D receptor gene polymorphisms on treatment of chronic HCV patients with interferon
ThesisInfluence of vitamin D receptor gene polymorphisms on treatment of chronic HCV patients with interferon
ThesisImpact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy
ThesisImpact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy
ThesisVitamin D serum level and CYP27B1-1260 promoter polymorphism in chronic hepatitis C patients treated with interferon
ThesisVitamin D serum level and CYP27B1-1260 promoter polymorphism in chronic hepatitis C patients treated with interferon